Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Nidan Laboratories and Healthcare Limited (NSE: NIDAN), ISIN INE0J6L01013 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
NIDAN last traded at ₹13.70 (+2.24%), with a 52-week range of ₹11.50 to ₹24.90 (as of 22 Sep 2026).
Shareholding as of Jun 2026: promoters 57.04%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 13/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.